Skip to content
中文产业新闻精选评分72Chinese source

阿斯利康终止PD-1/CTLA-4双抗volrustomig III期NSCLC试验

突发!阿斯利康终止PD-1/CTLA-4双抗III期NSCLC研究

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.